65,437 trials
Solid Tumors
Primary: Number of Participants With Treatment Emergent Adverse Events (TEAEs), Serious TEAEs, Treatment Related TEAEs and Treatment Related Serious TEAEs — 49; 7; 9; 20…
Lower Extremity Fracture
Primary: Patient-reported Pain — 5.3; 6.1 units on a scale
Triple Negative Breast Cancer
Primary: Percent Change in the Peripheral Immunoscore (PIS) at Week 6 — 30.63; -21.9; 32.285 % Change in PIS
Avascular Necrosis of Hip · Osteoarthritis, Hip · Rheumatoid Arthritis
Primary: Implant Survival — 95.39 percentage of participants
Multiple Myeloma
Primary: Rate of Stringent Complete Response — 1 Participants
Alcohol Use Disorder · Alcohol Drinking · Alcohol Use Disorder (AUD)
Primary: Alcohol Craving — 6.44; 6.26 score on a scale — p=0.784
Carotid Artery Stenosis · Carotid Artery Disease · Transient Ischemic Attack
Primary: Percentage of Patients Having a Significant Change in Neuropsychometric Performance After Carotid Endarterectomy — 22; 4.5 percentage of participants
Primary IgA Nephropathy
Primary: Part A: Ratio of Urine Protein to Creatinine Ratio (UPCR) at 9 Months Compared to Baseline — 0.69; 0.95 ratio — p=0.0003
Type 1 Diabetes Mellitus With Hypoglycemia
Primary: Incidence of All AEs in Cohort 1 Participants — 33; 2; 24; 8 Adverse Events
Multiple Sclerosis · Fatigue · Activity, Motor
Primary: Average Daily Use — 19.72 Minutes
VAP - Ventilator Associated Pneumonia
Primary: Total Number of Deaths in the Pre vs Post-intervention Time Periods Among Study Participants Per 1000 Mechanically Ventilated Patient Days — 72; 73 Deaths per 1000…
COVID-19
Primary: Percentage of Participants Who Completed a COVID-19 Test — 0.44; 0.40 percentage of participants
Actinic Keratoses
Primary: Efficacy of Tixel for Treatment of Actinic Keratosis — -90.4 percentage change
Type2 Diabetes
Primary: Change in Diabetes Knowledge
Renal Failure
Primary: Mean Standardized Weekly Kt/V (Efficacy) — 2.4; 3.0 Kt/V